| Value | ₹30.00 Cr |
|---|---|
| Execution period | within 6 months |
BSE filing, NSE: TIRFOAM. Summary written from the filing by ALFA Finder's alert engine.
Tirupati Foam Ltd: key numbers
- Share price
- ₹64.50
- Market cap
- ₹28.43 Cr
- Revenue (annual)
- ₹95.01 Cr
- Net profit (annual)
- ₹1.92 Cr
- P/E (TTM)
- 13.1×Sector 34.1×
- Promoter holding
- 70.04%-1.68% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tirupati Foam Ltd
All →Tirupati Foam Board Meeting Date
Tirupati Foam Ltd has scheduled its Board Meeting for 6 Nov 2026 to approve Q1 and half-year results. The trading window is closed until 48 hours post-results.
Tirupati Foam Other Announcement
Tirupati Foam Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI listing regulations.
Tirupati Foam Promoter Selling
Promoter Kalpesh Babulal Kothari sold 7,712 shares (0.17% stake) of Tirupati Foam Limited via open market transactions.
- Promoter stake change
- -0.17%
Tirupati Foam Promoter Selling
Tirupati Foam promoter group's Kalpesh B Kothari sold 13,717 equity shares (0.311%) in the open market. His stake fell from 1.535% to 1.224%.
Tirupati Foam Promoter Selling
Promoter Kalpesh B Kothari sold 21 Tirupati Foam shares in the open market on 8 Sept 2026. His stake fell marginally from 1.536% to 1.535%.
Tirupati Foam Annual General Meeting
Tirupati Foam Ltd held its 39th Annual General Meeting on 20th August 2026. Shareholders considered agenda items including dividend approval and disposal of Noida assets.
Other merger & restructuring announcements
All →Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr